- Role of PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia
-
Tomlinson B, Patil NG, Fok M, Lam CWK
- KMID: 2515455
- Endocrinol Metab.
- 2021 Apr;36(2):279-295.
- doi: 10.3803/EnM.2021.964
Patients with familial hypercholesterolemia (FH) are at high or very high risk for cardiovascular disease. Those with heterozygous FH (HeFH) often do not reach low-density lipoprotein cholesterol (LDL-C) targets with... -
- CITED
-
- Close
- SHARE
-
- Close
